文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

人血白蛋白输注对脓毒症患者微循环、毛细血管渗漏及内皮功能的影响:回顾性队列研究

Effects of Human Serum Albumin Infusion on Microcirculation, Capillary Leakage, and Endothelial Function in Sepsis Patients: A Retrospective Cohort Study.
PubMed 文献 · Shock · 2025-11-11
一句话结论在非重症低白蛋白血症脓毒症患者中,白蛋白复苏较晶体液改善72小时微循环、减少毛细血管渗漏并降低急性肾损伤发生率。

该回顾性队列研究纳入2022年1月至2024年12月同一医院收治的脓毒症患者223例,按液体复苏类型分为白蛋白组(n=115)与晶体液组(n=108)。白蛋白组72小时微血管血流指数(2.87 vs 2.73,P=0.003)、组织氧饱和度(80.14% vs 78.32%,P=0.002)更高,白蛋白渗漏率更低(30.35% vs 33.16%,P=0.006),一氧化氮水平更高(25.83 vs 24.56 μmol/L,P=0.003)。白蛋白组急性肾损伤发生率更低(14.78% vs 25.93%,P=0.038),ICU停留时间更短(7.57 vs 8.31天,P=0.006)。白蛋白治疗独立降低微循环恶化风险(P<0.001)。

要点

  • 非重症低白蛋白血症脓毒症患者中,白蛋白组72小时微血管血流指数2.87 vs 晶体液组2.73(P=0.003),组织氧饱和度80.14% vs 78.32%(P=0.002)。
  • 白蛋白组72小时白蛋白渗漏率30.35% vs 晶体液组33.16%(P=0.006),一氧化氮25.83 vs 24.56 μmol/L(P=0.003)。
  • 白蛋白组急性肾损伤发生率14.78% vs 晶体液组25.93%(P=0.038),ICU停留时间7.57 vs 8.31天(P=0.006)。
  • 白蛋白治疗独立降低微循环恶化风险(P<0.001)。
  • 研究为回顾性队列,纳入同一医院2022年1月至2024年12月脓毒症患者223例。

适用人群与场景

  • 纳入同一医院2022年1月至2024年12月收治的脓毒症患者,共223例(晶体液组n=108,白蛋白组n=115)。
  • 研究对象为低白蛋白血症且非重症的脓毒症患者。

研究设计与关键结果

  • 回顾性队列研究,纳入223例脓毒症患者,白蛋白组n=115,晶体液组n=108。
  • 72小时微循环:白蛋白组微血管血流指数2.87 vs 晶体液组2.73(P=0.003),组织氧饱和度80.14% vs 78.32%(P=0.002)。
  • 72小时毛细血管渗漏:白蛋白组白蛋白渗漏率30.35% vs 晶体液组33.16%(P=0.006)。
  • 72小时内皮功能:白蛋白组一氧化氮25.83 vs 晶体液组24.56 μmol/L(P=0.003)。
  • 白蛋白组急性肾损伤发生率14.78% vs 晶体液组25.93%(P=0.038)。
  • 白蛋白组ICU停留时间7.57 vs 晶体液组8.31天(P=0.006)。
  • 白蛋白治疗独立降低微循环恶化风险(P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在非重症低白蛋白血症脓毒症患者中,白蛋白复苏较晶体液复苏可能改善72小时微循环、减少毛细血管渗漏、改善内皮功能并降低急性肾损伤发生率、缩短ICU停留时间。
  • 作者认为,在非重症低白蛋白血症脓毒症患者中,白蛋白复苏通过改善微循环、内皮完整性和器官结局提供多靶点获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis and its associated microcirculatory and endothelial dysfunction leading to organ failure remained the primary causes of morbidity and mortality in intensive care units. Fluid resuscitation served as the cornerstone of early supportive therapy. This study aimed to evaluate the impact of human albumin (HA) versus crystalloid-based resuscitation on microcirculation, capillary leakage, and endothelial function in sepsis patients with hypoalbuminemia who are not severely ill.

METHODS: This retrospective cohort study included sepsis patients admitted to the same hospital between January 2022 and December 2024. Patients were divided into two groups based on the type of fluid resuscitation received: HA or crystalloids. Key parameters assessed included microcirculatory parameters, markers of capillary leakage, endothelial function, inflammatory markers, and albumin function within 72 hours, with organ support outcomes and clinical indicators evaluated at 4 weeks.

RESULTS: The study included 223 patients (crystalloid group: n = 108; HA group: n = 115). The HA group showed superior microcirculatory perfusion at 72 hours (microvascular flow index: 2.87 vs. 2.73, P = 0.003; tissue oxygen saturation: 80.14% vs. 78.32%, P = 0.002), reduced capillary leakage (albumin leakage: 30.35% vs. 33.16%, P = 0.006), and improved endothelial function at 72 hours (nitric oxide: 25.83 vs . 24.56 μmol/L, P = 0.003). The incidence of acute kidney injury was lower (14.78% vs. 25.93%, P = 0.038), and intensive care unit stay duration was shorter (7.57 vs. 8.31 days, P = 0.006). Albumin treatment independently reduced the risk of microcirculatory deterioration ( P < 0.001).

CONCLUSIONS: In hypoalbuminemic sepsis patients who are not severely ill, HA resuscitation provided multitarget benefits by improving microcirculation, endothelial integrity, and organ outcomes.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ren D, Liu Y, Qin Y, et al. Effects of Human Serum Albumin Infusion on Microcirculation, Capillary Leakage, and Endothelial Function in Sepsis Patients: A Retrospective Cohort Study. Shock. 2025. PMID: 41427814. doi:10.1097/SHK.0000000000002758

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。